SCHEMBL15733211

SCHEMBL15733211

COCCOC(=O)c1cccc(C)c1N

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.65
CYP2D6 P10635 1/20 0.61
CYP19A1 P11511 1/20 0.61
CYP2C9 P11712 1/20 0.61
CYP2C19 P33261 1/20 0.61
ALDH1A1 P00352 8/20 0.45
HSD17B10 Q99714 5/20 0.45
RAB9A P51151 5/20 0.44
NPC1 O15118 4/20 0.44
HPGD P15428 3/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
TP53 P04637 2/20 0.44
CYP3A4 P08684 2/20 0.44
MAPK1 P28482 2/20 0.44
GLA P06280 1/20 0.44
HIF1A Q16665 1/20 0.44
KDM4E B2RXH2 2/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15733367 0.94 CYP2D6 (0.67) TSHRCYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL15733096 0.86 CYP2D6 (0.59) TSHRCYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL19994754 0.86 ALDH1A1 (0.64) TSHRCYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL5808886 0.83 ALDH1A1 (0.64) TSHRCYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL11332129 0.83 CYP2D6 (0.56) TSHRCYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL14409194 0.83 TSHR (0.79) TSHRALDH1A1HSD17B10RAB9ANPC1
SCHEMBL27519835 0.83 ALDH1A1 (0.66) TSHRCYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL28589777 0.82 CYP2D6 (0.55) TSHRCYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL14645882 0.82 TSHR (0.67) TSHRCYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL9078373 0.81 TSHR (0.65) TSHRCYP2D6CYP19A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169198-B2 Method for the production of 2-amino-5-cyano-N,3-dimethylbenzamide BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-10-27 US disclosed
US-20140148611-A1 METHOD FOR THE PRODUCTION OF 2-AMINO-5-CYANO-N,3-DIMETHYLBENZAMIDE BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140148611-A1 METHOD FOR THE PRODUCTION OF 2-AMINO-5-CYANO-N,3-DIMETHYLBENZAMIDE ALKBH5, ALKBH2, MMAB TSHR 4356/4885CYP2D6 443/4885CYP19A1 1729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.